Magnus Financial Group’s Haemonetics HAE Stock Holding History

Magnus Financial Group’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,273	Closed	-$227K	–	525
2018 Q4	$227K	Buy	+2,273	New	+$239K	0.06%	304

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Magnus Financial Group's HAE Position: Q1 2019 in Review

Magnus Financial Group sold out of Haemonetics (HAE) in Q1 2019, closing a stake of 2,273 shares — an estimated $227K sold.

Magnus Financial Group first reported a position in HAE in Q4 2018 and held it in 1 quarter. The position peaked at $227K in Q4 2018. 260 funds tracked by Wall St. Rank hold HAE as of Q1 2019.

Magnus Financial Group reported no remaining Haemonetics position as of Q1 2019 after selling out during the quarter.
Magnus Financial Group sold 2,273 Haemonetics shares in Q1 2019, an estimated $227K.
Magnus Financial Group first reported a position in Haemonetics in Q4 2018 and held it in 1 quarter.
Magnus Financial Group's Haemonetics position peaked at $227K in Q4 2018.
260 funds tracked by Wall St. Rank held Haemonetics as of Q1 2019.

Based on Magnus Financial Group's 13F filing for Q1 2019, filed 9 May 2019.